Pregnancy outcomes are similar for women who continue to use vedolizumab to maintain remission from IBD compared to those who use anti-TNF or conventional non-biologic therapies, a European study has shown. An analysis of pregnancy and neonatal outcomes for 402 women who took IBD therapies during pregnancy found no difference overall in terms of miscarriage, ...
Vedolizumab appears safe to continue in pregnancy: study
By Michael Woodhead
12 Mar 2019